A veteran interventional cardiologist lost his right arm in an accident, but did not let that stop him from returning to his patients. 

The new drug-eluting device was designed to provide both stability and flexibility to patients presenting with below-the-knee lesions.  

After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks. 

The ACC launched its latest registry knowing that volumes at these outpatient facilities are expected to rise in the years ahead. 

The panel's decision will be based on data from the TRILUMINATE study, which was ultimately positive for Abbott, but did lead to certain questions about patient outcomes.

The rise of TAVR as a go-to treatment option for many AS patients has been one of the biggest stories in cardiology for several years now. How will advanced AI models impact this trend going forward? 

Hospital end users ranked the CVIS and hemodynamic systems they use, shedding light on their working relationships with IT vendors. 

The VIRTUE and POLARIS studies are both focused on evaluating how the Varipulse PFA Platform performs in a variety of clinical scenarios.